SYS-6002

N/A

Report date: 2026/04/14 20:00:15

Base Information

Drug NameSYS-6002
Drug Alias NameSYS-6002SYS6002CRB-701
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linker > VC linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Payload > MMAE payloadBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized +[4] 
Mechanisms of ActionAnti-NECTIN4Tubulin polymerisation inhibitors
TargetsNectin-4Tubulin
Therapy Area/IndicationsSolid tumoursUterine Cervical NeoplasmsCarcinoma, Transitional Cell +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesRomaniaItaly +[7] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesJushi Biopharmaceutical Co LtdCSPC Pharmaceutical Group Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesCorbus Pharmaceuticals Holdings IncCSPC Megalith Biopharmaceutical Co LtdJushi Biopharmaceutical Co Ltd +[5] 
Inactive CompaniesN/A
Active IndicationsSolid tumoursUterine Cervical NeoplasmsCarcinoma, Transitional Cell +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A